Last reviewed · How we verify

Nifedipine GITS

Peking University First Hospital · FDA-approved active Small molecule

Nifedipine GITS is a Calcium channel blocker (dihydropyridine) Small molecule drug developed by Peking University First Hospital. It is currently FDA-approved for Hypertension, Angina pectoris. Also known as: Adalat.

Nifedipine GITS is a long-acting calcium channel blocker that reduces calcium influx into vascular smooth muscle cells, causing vasodilation and lowering blood pressure.

Nifedipine GITS is a long-acting calcium channel blocker that reduces calcium influx into vascular smooth muscle cells, causing vasodilation and lowering blood pressure. Used for Hypertension, Angina pectoris.

At a glance

Generic nameNifedipine GITS
Also known asAdalat
SponsorPeking University First Hospital
Drug classCalcium channel blocker (dihydropyridine)
TargetL-type voltage-gated calcium channel
ModalitySmall molecule
Therapeutic areaCardiovascular
PhaseFDA-approved

Mechanism of action

Nifedipine blocks L-type calcium channels in the cell membrane, preventing calcium entry into vascular smooth muscle and cardiac cells. This reduces intracellular calcium concentration, leading to relaxation of vascular smooth muscle and decreased peripheral vascular resistance. The GITS (Gastrointestinal Therapeutic System) formulation provides sustained release over 24 hours, enabling once-daily dosing for improved patient compliance in hypertension management.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Nifedipine GITS

What is Nifedipine GITS?

Nifedipine GITS is a Calcium channel blocker (dihydropyridine) drug developed by Peking University First Hospital, indicated for Hypertension, Angina pectoris.

How does Nifedipine GITS work?

Nifedipine GITS is a long-acting calcium channel blocker that reduces calcium influx into vascular smooth muscle cells, causing vasodilation and lowering blood pressure.

What is Nifedipine GITS used for?

Nifedipine GITS is indicated for Hypertension, Angina pectoris.

Who makes Nifedipine GITS?

Nifedipine GITS is developed and marketed by Peking University First Hospital (see full Peking University First Hospital pipeline at /company/peking-university-first-hospital).

Is Nifedipine GITS also known as anything else?

Nifedipine GITS is also known as Adalat.

What drug class is Nifedipine GITS in?

Nifedipine GITS belongs to the Calcium channel blocker (dihydropyridine) class. See all Calcium channel blocker (dihydropyridine) drugs at /class/calcium-channel-blocker-dihydropyridine.

What development phase is Nifedipine GITS in?

Nifedipine GITS is FDA-approved (marketed).

What are the side effects of Nifedipine GITS?

Common side effects of Nifedipine GITS include Headache, Peripheral edema, Flushing, Dizziness, Palpitations.

What does Nifedipine GITS target?

Nifedipine GITS targets L-type voltage-gated calcium channel and is a Calcium channel blocker (dihydropyridine).

Related